There will be folks out there who think a delay in finalising the trial protocol is a setback.
They still need to revise it and then go back to the FDA for approval. But I think we knew this already so its not actually news.
Ann: FDA feedback on Pivotal Protocol, page-4
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.040(1.68%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.43 | $2.33 | $1.728M | 733.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4407 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 16721 | 2 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |